Literature DB >> 23562508

ADAMTS1, ADAMTS5, ADAMTS9 and aggrecanase-generated proteoglycan fragments are induced following spinal cord injury in mouse.

Kadir Demircan1, Tomoko Yonezawa, Tomoyuki Takigawa, Vehap Topcu, Serpil Erdogan, Fatma Ucar, Ferah Armutcu, M Ramazan Yigitoglu, Yoshifumi Ninomiya, Satoshi Hirohata.   

Abstract

ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) proteinases are involved in a variety of biological processes such as angiogenesis, cancer and arthritis. ADAMTSs appears to be responsible for the cleavage of proteoglycans in several tissues including brain and cartilage. Chondroitin sulfate proteoglycans (CSPGs) maintains the integrity of the brain extracellular matrix and major inhibitory contributors for glial scar and neural plasticity. The activity of aggrecanases in the central nervous system (CNS) has been reported. ADAMTSs are an enzyme degrading CSPGs in the brain. However, there is a little knowledge regarding ADAMTSs in the CNS. We investigated the expression levels of ADAMTSs mRNAs by RT-PCR after spinal cord injury in mouse. Transcripts encoding 4 of the 19 known ADAMTSs were evaluated in the mouse spinal cord following injury. ADAMTS1, -5 and -9 expression levels were found to be upregulated. No change was observed in ADAMTS4 expression. By means of immunohistochemistry, ADAMTSs were detected in the astrocytes implying its cellular source in SCI. Western blot analyses indicated that aggrecanase-generated proteoglycan fragments are produced after SCI.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562508     DOI: 10.1016/j.neulet.2013.02.064

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

Review 1.  Advances in ex vivo models and lab-on-a-chip devices for neural tissue engineering.

Authors:  Sahba Mobini; Young Hye Song; Michaela W McCrary; Christine E Schmidt
Journal:  Biomaterials       Date:  2018-05-11       Impact factor: 12.479

2.  The extracellular metalloprotease AdamTS-A anchors neural lineages in place within and preserves the architecture of the central nervous system.

Authors:  James B Skeath; Beth A Wilson; Selena E Romero; Mark J Snee; Yi Zhu; Haluk Lacin
Journal:  Development       Date:  2017-07-31       Impact factor: 6.868

3.  Increased metalloproteinase activity in the hippocampus following status epilepticus.

Authors:  Deepti Dubey; Paulette A McRae; Elyse K Rankin-Gee; Esther Baranov; Luke Wandrey; Stephanie Rogers; Brenda E Porter
Journal:  Epilepsy Res       Date:  2017-03-01       Impact factor: 3.045

4.  Diversity of developing peripheral glia revealed by single-cell RNA sequencing.

Authors:  Ozge E Tasdemir-Yilmaz; Noah R Druckenbrod; Olubusola O Olukoya; Weixiu Dong; Andrea R Yung; Isle Bastille; Maria F Pazyra-Murphy; Austen A Sitko; Evan B Hale; Sébastien Vigneau; Alexander A Gimelbrant; Peter V Kharchenko; Lisa V Goodrich; Rosalind A Segal
Journal:  Dev Cell       Date:  2021-08-31       Impact factor: 13.417

Review 5.  Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease.

Authors:  Murat Serdar Gurses; Mustafa Numan Ural; Mehmet Akif Gulec; Omer Akyol; Sumeyya Akyol
Journal:  Aging Dis       Date:  2016-01-11       Impact factor: 6.745

Review 6.  ADAMTS-5: A difficult teenager turning 20.

Authors:  Salvatore Santamaria
Journal:  Int J Exp Pathol       Date:  2020-03-27       Impact factor: 1.925

7.  Local Delivery of High-Dose Chondroitinase ABC in the Sub-Acute Stage Promotes Axonal Outgrowth and Functional Recovery after Complete Spinal Cord Transection.

Authors:  Chu-Hsun Cheng; Chi-Te Lin; Meng-Jen Lee; May-Jywan Tsai; Wen-Hung Huang; Ming-Chao Huang; Yi-Lo Lin; Ching-Jung Chen; Wen-Cheng Huang; Henrich Cheng
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

Review 8.  ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Authors:  Sighild Lemarchant; Mathilde Pruvost; Joan Montaner; Evelyne Emery; Denis Vivien; Katja Kanninen; Jari Koistinaho
Journal:  J Neuroinflammation       Date:  2013-10-31       Impact factor: 8.322

9.  ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.

Authors:  Kadir Demircan; Vehap Topcu; Tomoyuki Takigawa; Sumeyya Akyol; Tomoko Yonezawa; Gulfer Ozturk; Veli Ugurcu; Rukiye Hasgul; M Ramazan Yigitoglu; Omer Akyol; Daniel R McCulloch; Satoshi Hirohata
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

10.  ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.

Authors:  Sighild Lemarchant; Yuriy Pomeshchik; Iurii Kidin; Virve Kärkkäinen; Piia Valonen; Sarka Lehtonen; Gundars Goldsteins; Tarja Malm; Katja Kanninen; Jari Koistinaho
Journal:  Mol Neurodegener       Date:  2016-01-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.